Cart
sales@molnova.com
p38α inhibitor 1
CAS No. 1034189-82-6
p38α inhibitor 1( P38alpha inhibitor 1 | ARRY-797 | P38a inhibitor 1 )
Catalog No. M26356 CAS No. 1034189-82-6
p38α inhibitor 1 is an inhibitor of p38α .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 45 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 42 | In Stock |
|
| 10MG | 67 | In Stock |
|
| 25MG | 136 | In Stock |
|
| 50MG | 197 | In Stock |
|
| 100MG | 276 | In Stock |
|
| 200MG | 368 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Namep38α inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief Descriptionp38α inhibitor 1 is an inhibitor of p38α .
-
Descriptionp38α inhibitor 1 is an inhibitor of p38α .
-
In Vitro——
-
In Vivo——
-
SynonymsP38alpha inhibitor 1 | ARRY-797 | P38a inhibitor 1
-
PathwayMAPK/ERK Signaling
-
Targetp38 MAPK
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1034189-82-6
-
Formula Weight416.473
-
Molecular FormulaC22H26F2N4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 125 mg/mL (300.15 mM)
-
SMILESCC(C)Cn1ncc2cc(Oc3ccc(F)cc3F)c(cc12)C(=O)NCCN(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Moncrieff M, Fadhil M, Garioch J. Topical diphencyprone for the treatment of locoregional intralymphatic melanoma metastases (LIMMs) of the skin. The 5-Year Norwich experience. Br J Dermatol. 2015 Nov 24.
molnova catalog
related products
-
Andrograpanin
Andrograpanin is a bioactive compound from Andrographis paniculata.
-
MW181 dihydrochlorid...
MW181 (MW01-10-181SRM) is an isoform-selective, brain-permeable, and orally bioavailable small molecule inhibitor of p38α MAPK with Ki of 184 nM.
-
Darizmetinib
Darizmetinib (HRX215, HRX-0215) is an MKK4 inhibitor. Inhibition of MKK4 leads to enhancement of the MKK7 and JNK1 signaling pathways, thereby activating the transcription factors ATF2 and ELK1, promoting cell proliferation and liver regeneration.
